AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2022
Feb 8, 2022
33298_dirs_2022-02-08_496cb372-8ad6-47a6-82ab-63cbeffd645d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2022-02-04
Reporting Person: STAN MARIA E. (Principal Accounting Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3125 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $0 | Common Stock (9375) | Direct | ||
| Stock Option (Right to Buy) | $19.61 | Common Stock (90000) | Direct |
Footnotes
F1: 3,125 RSUs will vest on each of July 15, 2022, July 15, 2023 and July 15, 2024
F2: The option vests in 36 equal amounts beginning on March 15, 2021.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17